{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:16:25Z","timestamp":1790864185186,"version":"4.1.0"},"reference-count":29,"publisher":"American Society for Microbiology","issue":"5","license":[{"start":{"date-parts":[[2009,5,1]],"date-time":"2009-05-01T00:00:00Z","timestamp":1241136000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Clin Vaccine Immunol"],"published-print":{"date-parts":[[2009,5]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Current diagnosis of human flaviviral infections relies heavily on serological techniques such as the immunoglobulin M (IgM) antibody capture enzyme-linked immunosorbent assay (MAC-ELISA). Broad application of this assay is hindered by a lack of standardized human positive-control sera that react with the wide variety of flaviviruses that can cause human disease, e.g., dengue virus (DENV), West Nile virus (WNV), yellow fever virus (YFV), Japanese encephalitis virus (JEV), and St. Louis encephalitis virus (SLEV). We have created a human-murine chimeric antibody combining the variable regions of the broadly flavivirus cross-reactive murine monoclonal antibody (MAb) 6B6C-1 and the constant region of human IgM to produce a standardized reagent capable of replacing human positive-control sera in a MAC-ELISA for the diagnosis of all human flaviviral infections. The human-murine chimeric IgM antibody secreted from plasmid-transformed Sp2\/0-Ag14 cells had a level of serological activity identical to that of 6B6C-1 as measured by ELISA, immunoblotting, and MAC-ELISA for multiple members of the flavivirus genus, including WNV, SLEV, YFV, DENV, and JEV.<\/jats:p>","DOI":"10.1128\/cvi.00354-08","type":"journal-article","created":{"date-parts":[[2009,3,18]],"date-time":"2009-03-18T21:44:45Z","timestamp":1237412685000},"page":"679-685","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":18,"title":["Development of a Human-Murine Chimeric Immunoglobulin M Antibody for Use in the Serological Detection of Human Flavivirus Antibodies"],"prefix":"10.1128","volume":"16","author":[{"given":"Brett A.","family":"Thibodeaux","sequence":"first","affiliation":[{"name":"Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 3150 Rampart Road, Fort Collins, Colorado 80521"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T.","family":"Roehrig","sequence":"additional","affiliation":[{"name":"Arboviral Diseases Branch, Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne and Enteric Diseases, Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services, 3150 Rampart Road, Fort Collins, Colorado 80521"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1988.38.172"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.9.4244-4252.2000"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0042-6822(02)00028-4","volume":"306","year":"2003","unstructured":"Chang, G. J., A. R. Hunt, D. A. Holmes, T. Springfield, T. S. Chiueh, J. T. Roehrig, and D. J. Gubler. 2003. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology306:170-180.","journal-title":"Virology"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.24.13975-13986.2004"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.9.4040-4047.2001"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1023\/A:1006321231510","volume":"18","year":"1999","unstructured":"Davis, G. C., M. L. Gallo, and J. R. F. Corvalan. 1999. Transgenic mice as a source of fully human antibodies for the treatment of cancer. Cancer Metastasis Rev.18:421-425.","journal-title":"Cancer Metastasis Rev."},{"key":"e_1_3_2_8_2","first-page":"133","volume":"2","year":"1997","unstructured":"Hackett, J., Jr., J. Hoff-Velk, A. Golden, C. Dealwis, D. Ostrow, and W. Mandecki. 1997. The effect of site-specific mutagenesis of a cysteine residue on the stability of a monoclonal antibody, p. 133-157. In W. Hori (ed.), Antibody engineering II,vol. 2. New technology, application and commercialization. International Business Communications, Inc., Southborough, MA.","journal-title":"Antibody engineering II"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.36.5.1277-1284.1998"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3227-3236.2005"},{"key":"e_1_3_2_11_2","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1046\/j.1537-2995.2003.00393.x","volume":"43","year":"2003","unstructured":"Huang, T. J., M. E. Reid, G. R. Halverson, and K. Yazdanbakhsh. 2003. Production of recombinant murine-human chimeric IgM and IgG anti-Jsb for use in the clinical laboratory. Transfusion43:758-764.","journal-title":"Transfusion"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0166-0934(01)00346-9","volume":"97","year":"2001","unstructured":"Hunt, A. R., C. B. Cropp, and G. J. Chang. 2001. A recombinant particulate antigen of Japanese encephalitis virus produced in stably-transformed cells is an effective noninfectious antigen and subunit immunogen. J. Virol. Methods97:133-149.","journal-title":"J. Virol. Methods"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.40.6.2023-2030.2002"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.5.1827-1831.2000"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/nar\/28.1.214","volume":"28","year":"2000","unstructured":"Johnson, G., and T. T. Wu. 2000. Kabat database and its applications: 30 years after the first variability plot. Nucleic Acids Res.28:214-218.","journal-title":"Nucleic Acids Res."},{"key":"e_1_3_2_16_2","first-page":"579","volume":"9","year":"1991","unstructured":"Jones, S. T., and M. M. Bendig. 1991. Rapid PCR-cloning of full-length mouse immunoglobulin variable regions. Biotechnology (New York)9:579.","journal-title":"Biotechnology (New York)"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/HAB-2002-11305","volume":"11","year":"2002","unstructured":"Kalantarov, G. F., S. A. Rudchenko, L. Lobel, and I. Trakht. 2002. Development of a fusion partner cell line for efficient production of human monoclonal antibodies from peripheral blood lymphocytes. Hum. Antibodies11:85-96.","journal-title":"Hum. Antibodies"},{"key":"e_1_3_2_18_2","first-page":"399","year":"1997","unstructured":"Kuby, J. 1997. Antibodies, p. 399. In J. Kuby (ed.), Immunology, 3rd ed. W. H. Freeman and Co., New York, NY.","journal-title":"Immunology"},{"key":"e_1_3_2_19_2","first-page":"757","year":"2006","unstructured":"Lanciotti, R. S., and J. T. Roehrig. 2006. Arboviruses, p. 757-765. In B. Detrick, R. G. Hamilton, and J. D. Folds (ed.), Manual of molecular and clinical laboratory immunology, 7th ed. ASM Press, Washington, DC.","journal-title":"Manual of molecular and clinical laboratory immunology"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.5.1823-1826.2000"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4049\/jimmunol.132.3.1533","volume":"132","year":"1984","unstructured":"Mathews, J. H., and J. T. Roehrig. 1984. Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J. Immunol.132:1533-1537.","journal-title":"J. Immunol."},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.42.10.4709-4717.2004"},{"key":"e_1_3_2_23_2","first-page":"356","year":"2000","unstructured":"Roehrig, J. T. 2000. Arboviruses, p. 356-373. In S. Specter, R. L. Hodinka, and S. A. Young (ed.), Clinical virology manual, 3rd ed. ASM Press, Washington, DC.","journal-title":"Clinical virology manual"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3201\/eid0903.020531","volume":"9","year":"2003","unstructured":"Roehrig, J. T., D. Nash, B. Maldin, A. Labowitz, D. A. Martin, R. S. Lanciotti, and G. L. Campbell. 2003. Persistence of virus-reactive serum immunoglobulin M antibody in confirmed West Nile virus encephalitis cases. Emerg. Infect. Dis.9:376-379.","journal-title":"Emerg. Infect. Dis."},{"key":"e_1_3_2_25_2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/0042-6822(83)90323-9","volume":"128","year":"1983","unstructured":"Roehrig, J. T., J. H. Mathews, and D. W. Trent. 1983. Identification of epitopes on the E glycoprotein of Saint Louis encephalitis virus using monoclonal antibodies. Virology128:118-126.","journal-title":"Virology"},{"key":"e_1_3_2_26_2","first-page":"223","volume":"267","year":"2002","unstructured":"Roehrig, J. T., M. Layton, P. Smith, G. L. Campbell, R. Nasci, and R. S. Lanciotti. 2002. The emergence of West Nile virus in North America: ecology, epidemiology, and surveillance. Curr. Top. Microbiol. Immunol.267:223-240.","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0076-6879(89)78034-4","volume":"178","year":"1989","unstructured":"Shin, S. U., and S. L. Morrison. 1989. Production and properties of chimeric antibody molecules. Methods Enzymol.178:459-476.","journal-title":"Methods Enzymol."},{"key":"e_1_3_2_28_2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/09273940490518937","volume":"13","year":"2005","unstructured":"Thibodeaux, B. A., A. R. Caballero, J. J. Dajcs, M. E. Marquart, L. S. Engel, and R. J. O'Callaghan. 2005. Pseudomonas aeruginosa protease IV: a corneal virulence factor of low immunogenicity. Ocul. Immunol. Inflamm.13:169-182.","journal-title":"Ocul. Immunol. Inflamm."},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","volume":"10","year":"2004","unstructured":"Traggiai, E., S. Becker, K. Subbarao, L. Kolesnikova, Y. Uematsu, M. R. Gismondo, B. R. Murphy, R. Rappuoli, and A. Lanzavecchia. 2004. An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat. Med.10:871-875.","journal-title":"Nat. Med."},{"key":"e_1_3_2_30_2","first-page":"1417","year":"1987","unstructured":"Tsai, T. F., and T. P. Monath. 1987. Viral diseases in North American transmitted by arthropods from vertebrate reservoirs, p. 1417-1456. In R. D. Feigin and J. D. Cherry, (ed.), Textbook of pediatric infectious diseases. W. B. Saunders Co., Philadelphia, PA.","journal-title":"Textbook of pediatric infectious diseases."}],"container-title":["Clinical and Vaccine Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00354-08","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/CVI.00354-08","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:12:12Z","timestamp":1684923132000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/CVI.00354-08"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,5]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,5]]}},"alternative-id":["10.1128\/CVI.00354-08"],"URL":"https:\/\/doi.org\/10.1128\/cvi.00354-08","relation":{},"ISSN":["1556-6811","1556-679X"],"issn-type":[{"value":"1556-6811","type":"print"},{"value":"1556-679X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,5]]},"assertion":[{"value":"2008-09-26","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2009-03-05","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-18","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}